Global Drug Discovery and Preclinical CRO Market Growth (Status and Outlook) 2023-2029

Global Drug Discovery and Preclinical CRO Market Growth (Status and Outlook) 2023-2029

The global Drug Discovery and Preclinical CRO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Drug Discovery and Preclinical CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Drug Discovery and Preclinical CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Drug Discovery and Preclinical CRO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Drug Discovery and Preclinical CRO players cover Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON plc, Pharmaron, Inotiv and ChemPartner, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Drug Discovery and Preclinical CRO Industry Forecast” looks at past sales and reviews total world Drug Discovery and Preclinical CRO sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Discovery and Preclinical CRO sales for 2023 through 2029. With Drug Discovery and Preclinical CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Discovery and Preclinical CRO industry.

This Insight Report provides a comprehensive analysis of the global Drug Discovery and Preclinical CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Discovery and Preclinical CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Discovery and Preclinical CRO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery and Preclinical CRO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery and Preclinical CRO.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery and Preclinical CRO market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Drug Discovery
Preclinical Research

Segmentation by application
Pharmaceutical Company
Biotech Company
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON plc
Pharmaron
Inotiv
ChemPartner
JOINN Laboratories
Evotec
Medicilon
Crown Bioscience
Champions Oncology
Frontage Laboratories
Viva Biotech
Hitgen Inc.
Shanghai Innostar

Please note: The report will take approximately 2 business days to prepare and deliver.